Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

15.22
Delayed Data
As of 4:00pm ET
 +0.29 / +1.94%
Today’s Change
4.72
Today|||52-Week Range
21.35
+171.79%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close14.93
Today’s open14.90
Day’s range14.68 - 15.54
Volume417,709
Average volume (3 months)551,361
Market cap$459.8M
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-5.41%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratioNM
Price/Sales5.59
Price/Book5.93

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...+0.03+2.03%
--Wang On Group Ltd+0.00+11.11%
XBITXBiotech Inc-0.19-4.53%
KMDAKamada Ltd-0.05-1.06%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Scott T. McMillan
Corporate headquarters
Amsterdam, Noord-holland

Forecasts